FDA (Drugs) recall action 77780
The FDA (Drugs) publishes a recall like this one as 18 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 18 pages.
Lack of Sterility Assurance.
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Cantrell Drug Company is recalling 8,928 bags of Norepinephrine Bitartrate 8 mg in 0.9% Sodium Chloride 250 mL due to a lack of sterility assurance.
Cantrell Drug Company is recalling Neostigmine Methylsulfate Injection Solution due to a lack of sterility assurance. The affected syringes were distributed nationwide.
Cantrell Drug Company is recalling specific lots of Rocuronium Bromide Injection Solution due to a lack of sterility assurance. The affected syringes were distributed nationwide in the US.
Cantrell Drug Company is recalling Ephedrine Sulfate syringes due to a lack of sterility assurance. The recall covers 49,666 syringes distributed nationwide.
Cantrell Drug Company is recalling specific lots of Succinylcholine Chloride Injection Solution due to a lack of sterility assurance.
Cantrell Drug Company is recalling specific lots of Succinylcholine Chloride Injection Solution due to a lack of sterility assurance.
Cantrell Drug Company is recalling 21,080 syringes of Glycopyrrolate Injection Solution due to a lack of sterility assurance.
Cantrell Drug Company is recalling 1,718 bags of Norepinephrine Bitartrate 16 mg in 0.9% Sodium Chloride 250 mL due to a lack of sterility assurance.
Cantrell Drug Company is recalling 3,039 bags of Norepinephrine Bitartrate 4 mg in 0.9% Sodium Chloride due to a lack of sterility assurance.
Cantrell Drug Company is recalling 75,840 syringes of Glycopyrrolate Injection Solution nationwide because of a lack of sterility assurance.
Cantrell Drug Company is recalling Ephedrine Sulfate in 0.9% Sodium Chloride single-dose syringes because of a lack of sterility assurance.
Cantrell Drug Company is recalling specific lots of Sodium Bicarbonate 8.4% Injection Solution because of a lack of sterility assurance.
Cantrell Drug Company is recalling specific lots of Phenylephrine HCL syringes because they may lack sterility assurance. The affected products were distributed nationwide.
Cantrell Drug Company is recalling Diltiazem HCl 125 mg in 5% Dextrose single-dose bags because of a lack of sterility assurance. The recall covers 2,761 bags distributed nationwide.
Cantrell Drug Company is recalling specific lots of Ephedrine Sulfate syringes due to a lack of sterility assurance. The affected products were distributed nationwide.
Cantrell Drug Company is recalling Adenosine in 0.9% Sodium Chloride syringes due to a lack of sterility assurance.
Cantrell Drug Company is recalling 7,656 syringes of Ephedrine Sulfate Injection Solution due to a lack of sterility assurance. The affected products were distributed nationwide.
Cantrell Drug Company is recalling specific lots of Glycopyrrolate Injection Solution due to a lack of sterility assurance. The affected syringes were distributed nationwide.